Brainstorm Cell Therapeutics. Earnings Calls

Q4 2024 (Upcoming)
Release date Apr 07, 2025
EPS estimate -$0.490
EPS actual -
Revenue estimate -
Revenue actual -
Expected change +/- 15.38%
Q3 2024 Missed
-$1.80 (-300.00%)
Release date Nov 14, 2024
EPS estimate -$0.450
EPS actual -$1.80
EPS Surprise -300.00%
Revenue estimate -
Revenue actual -
Q2 2024
Release date Aug 14, 2024
EPS estimate -$0.600
EPS actual -$0.600
Revenue estimate -
Revenue actual 365K
Q1 2024 Beat
-$1.65 (26.67%)
Release date Apr 01, 2024
EPS estimate -$2.25
EPS actual -$1.65
EPS Surprise 26.67%
Revenue estimate -
Revenue actual -569000

Last 4 Quarters for Brainstorm Cell Therapeutics.

Below you can see how BCLI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q1 2024 Beat
Release date Apr 01, 2024
Fiscal end date Mar 31, 2024
Price on release $0.740
EPS estimate -$2.25
EPS actual -$1.65
EPS surprise 26.67%
Date Price
Mar 25, 2024 $0.655
Mar 26, 2024 $0.660
Mar 27, 2024 $0.600
Mar 28, 2024 $0.565
Apr 01, 2024 $0.740
Apr 02, 2024 $0.719
Apr 03, 2024 $0.689
Apr 04, 2024 $0.675
Apr 05, 2024 $0.651
4 days before 12.96%
4 days after -12.02%
On release day -2.82%
Change in period -0.611%
Q2 2024
Release date Aug 14, 2024
Fiscal end date Jun 30, 2024
Price on release $0.305
EPS estimate -$0.600
EPS actual -$0.600
Date Price
Aug 08, 2024 $0.245
Aug 09, 2024 $0.259
Aug 12, 2024 $0.294
Aug 13, 2024 $0.319
Aug 14, 2024 $0.305
Aug 15, 2024 $0.313
Aug 16, 2024 $0.341
Aug 19, 2024 $0.382
Aug 20, 2024 $0.357
4 days before 24.58%
4 days after 16.95%
On release day 2.65%
Change in period 45.69%
Q3 2024 Missed
Release date Nov 14, 2024
Fiscal end date Sep 30, 2024
Price on release $1.13
EPS estimate -$0.450
EPS actual -$1.80
EPS surprise -300.00%
Date Price
Nov 08, 2024 $1.20
Nov 11, 2024 $1.22
Nov 12, 2024 $1.18
Nov 13, 2024 $1.17
Nov 14, 2024 $1.13
Nov 15, 2024 $1.21
Nov 18, 2024 $1.22
Nov 19, 2024 $1.29
Nov 20, 2024 $1.25
4 days before -5.83%
4 days after 10.62%
On release day 7.08%
Change in period 4.17%
Q4 2024 (Upcoming)
Release date Apr 07, 2025
Fiscal end date Dec 30, 2024
Price on release -
EPS estimate -$0.490
EPS actual -
Date Price
Feb 10, 2025 $1.72
Feb 11, 2025 $1.74
Feb 12, 2025 $1.78
Feb 13, 2025 $1.80
Feb 14, 2025 $1.86

Brainstorm Cell Therapeutics. Earnings History

Earnings Calendar

FAQ

When is the earnings report for BCLI?
Brainstorm Cell Therapeutics Inc. (BCLI) has scheduled its earnings report for Apr 07, 2025 before the markets open.

What is the BCLI price-to-earnings (P/E) ratio?
BCLI P/E ratio as of Feb 14, 2025 (TTM) is -0.664.

What is the BCLI EPS forecast?
The forecasted EPS (Earnings Per Share) for Brainstorm Cell Therapeutics Inc. (BCLI) for the first fiscal quarter 2024 is -$0.490.

What are Brainstorm Cell Therapeutics Inc.'s retained earnings?
On its balance sheet, Brainstorm Cell Therapeutics Inc. reported retained earnings of $0 for the latest quarter ending Sep 30, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT BRAINSTORM CELL THERAPEUTICS INC.
Brainstorm Cell Therapeutics.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ...
GOLDEN STAR
Ticker Change Signal Date
T
TBIL
$49.90
0.0802% Feb 12
I
IBTF
$23.33
0.0429% Feb 12
SKT
$33.58
2.00% Feb 12
BSY
$46.63
1.33% Feb 11
IBN
$29.02
0.482% Feb 11

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE